A risk calculator predicting recurrence in lymph node metastatic penile cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Marco,Bandini ^[1] ; Philippe E,Spiess ^[2] ; Filippo,Pederzoli ^[1] ; Laura,Marandino ^[3] ; Oscar R,Brouwer ^[4] ; Maarten,Albersen ^[5] ; Eduard,Roussel ^[5] ; Hielke M,de Vries ^[4] ; Juan,Chipollini ^[2] ; Yao,Zhu ^[6] ; Ding-Wei,Ye ^[6] ; Antonio A,Ornellas ^[7] ; Mario,Catanzaro ^[3] ; Oliver W,Hakenberg ^[8] ; Axel,Heidenreich ^[9] ; Friederike,Haidl ^[9] ; Nick,Watkin ^[10] ; Michael,Ager ^[10] ; Mohamed E,Ahmed ^[11] ; Jeffrey R,Karnes ^[11] ; Alberto,Briganti ^[1] ; Roberto,Salvioni ^[3] ; Francesco,Montorsi ^[1] ; Mounsif,Azizi ^[2] ; Andrea,Necchi ^[3]

作者单位： Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. ^[1] Moffitt Cancer Center and Research Institute, Tampa, FL, USA. ^[2] Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. ^[3] The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. ^[4] University Hospitals Leuven, Leuven, Belgium. ^[5] Fudan University Shanghai Cancer Center, Shanghai, China. ^[6] Hospital Mário Kröeff and Brazilian Cancer Institute, Rio de Janeiro, Brazil. ^[7] University Hospital Rostock, Rostock, Germany. ^[8] Universitätsklinikum Köln, Köln, Germany. ^[9] St. George's University Hospitals, NHS Foundation Trust, London, UK. ^[10] Department of Urology, Mayo Clinic, Rochester, MN, USA. ^[11]

关键词 #PenileCancer #uroonc adjuvant treatments inguinal lymph node metastases penile cancer recurrence risk calculator